JPS63119763A - Emergency adhesive plaster - Google Patents
Emergency adhesive plasterInfo
- Publication number
- JPS63119763A JPS63119763A JP25558987A JP25558987A JPS63119763A JP S63119763 A JPS63119763 A JP S63119763A JP 25558987 A JP25558987 A JP 25558987A JP 25558987 A JP25558987 A JP 25558987A JP S63119763 A JPS63119763 A JP S63119763A
- Authority
- JP
- Japan
- Prior art keywords
- drug
- pad
- coating film
- wound
- sheet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000853 adhesive Substances 0.000 title claims description 14
- 230000001070 adhesive effect Effects 0.000 title claims description 14
- 239000011505 plaster Substances 0.000 title 1
- 239000003814 drug Substances 0.000 claims description 51
- 229940079593 drug Drugs 0.000 claims description 49
- 239000011248 coating agent Substances 0.000 claims description 23
- 238000000576 coating method Methods 0.000 claims description 23
- 206010052428 Wound Diseases 0.000 description 16
- 208000027418 Wounds and injury Diseases 0.000 description 16
- 239000012528 membrane Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 229940030225 antihemorrhagics Drugs 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000002874 hemostatic agent Substances 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- SIACJRVYIPXFKS-UHFFFAOYSA-N (4-sulfamoylphenyl)methylazanium;chloride Chemical compound Cl.NCC1=CC=C(S(N)(=O)=O)C=C1 SIACJRVYIPXFKS-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- OJFZXRZZXBFEAP-UHFFFAOYSA-N 5-chloro-1,6-dimethylcyclohexa-2,4-dien-1-ol Chemical compound ClC=1C(C(C=CC1)(C)O)C OJFZXRZZXBFEAP-UHFFFAOYSA-N 0.000 description 1
- DEVFVVLSBJSUNB-UHFFFAOYSA-N 7h-purine;hydrochloride Chemical compound Cl.N1=CNC2=NC=NC2=C1 DEVFVVLSBJSUNB-UHFFFAOYSA-N 0.000 description 1
- IYLLULUTZPKQBW-UHFFFAOYSA-N Acrinol Chemical compound CC(O)C(O)=O.C1=C(N)C=CC2=C(N)C3=CC(OCC)=CC=C3N=C21 IYLLULUTZPKQBW-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 1
- ITRJWOMZKQRYTA-RFZYENFJSA-N Cortisone acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)CC2=O ITRJWOMZKQRYTA-RFZYENFJSA-N 0.000 description 1
- BALXUFOVQVENIU-GNAZCLTHSA-N Ephedrine hydrochloride Chemical compound Cl.CN[C@@H](C)[C@H](O)C1=CC=CC=C1 BALXUFOVQVENIU-GNAZCLTHSA-N 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 1
- PPWHTZKZQNXVAE-UHFFFAOYSA-N Tetracaine hydrochloride Chemical compound Cl.CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 PPWHTZKZQNXVAE-UHFFFAOYSA-N 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical group [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229960005274 benzocaine Drugs 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 229960002645 boric acid Drugs 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229940046978 chlorpheniramine maleate Drugs 0.000 description 1
- 229960003290 cortisone acetate Drugs 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 229960001378 dequalinium chloride Drugs 0.000 description 1
- LTNZEXKYNRNOGT-UHFFFAOYSA-N dequalinium chloride Chemical compound [Cl-].[Cl-].C1=CC=C2[N+](CCCCCCCCCC[N+]3=C4C=CC=CC4=C(N)C=C3C)=C(C)C=C(N)C2=C1 LTNZEXKYNRNOGT-UHFFFAOYSA-N 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003657 dexamethasone acetate Drugs 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 229960002534 ephedrine hydrochloride Drugs 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 239000011086 glassine Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- AHXDSVSZEZHDLV-UHFFFAOYSA-N mesulfen Chemical compound CC1=CC=C2SC3=CC(C)=CC=C3SC2=C1 AHXDSVSZEZHDLV-UHFFFAOYSA-N 0.000 description 1
- 229960005479 mesulfen Drugs 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000004081 narcotic agent Substances 0.000 description 1
- IAIWVQXQOWNYOU-FPYGCLRLSA-N nitrofural Chemical compound NC(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 IAIWVQXQOWNYOU-FPYGCLRLSA-N 0.000 description 1
- 229960001907 nitrofurazone Drugs 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- 229960002800 prednisolone acetate Drugs 0.000 description 1
- PVYDNJADTSAQQU-UHFFFAOYSA-N prop-1-ene;hydrochloride Chemical compound Cl.CC=C PVYDNJADTSAQQU-UHFFFAOYSA-N 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 1
- YZMCKZRAOLZXAZ-UHFFFAOYSA-N sulfisomidine Chemical compound CC1=NC(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 YZMCKZRAOLZXAZ-UHFFFAOYSA-N 0.000 description 1
- 229960001975 sulfisomidine Drugs 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 229960002494 tetracaine hydrochloride Drugs 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fuses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。(57) [Abstract] This bulletin contains application data before electronic filing, so abstract data is not recorded.
Description
【発明の詳細な説明】
一般に繁用の簡易救急絆創膏は、１！ｊ菌消凄剤、創傷
治療剤を含浸させたガーゼを通気孔を有する粘着性のシ
ートに装着し、使用時に裏面の剥離紙をはがして前記ガ
ーゼ部を傷口局所に当てて使用するようにしたものであ
る。[Detailed Description of the Invention] Commonly used simple emergency bandages are 1! A gauze impregnated with a germ-killing agent and a wound treatment agent was attached to an adhesive sheet with ventilation holes, and when used, the release paper on the back was peeled off and the gauze section was applied to the wound. It is something.
しかしながら、これらの従来品においては。However, in these conventional products.
予めガーゼに薬液を含浸させておくため、経時的に薬液
が蒸散し、また効力の・失活をきたすばかりでなく、局
所への当接に際してはガーゼ部が乾燥状態となっている
ため、傷口をいためるおそれがあり、使用に際しても、
痛みを感じさせる等の欠点があった。Since the gauze is impregnated with the medicinal solution in advance, the medicinal solution evaporates over time and not only loses its effectiveness, but also causes the gauze to be dry when applied to the wound. There is a risk of damaging the
It had drawbacks such as causing pain.
また、薬剤被覆膜により薬剤をシールしたブリスター部
を有する救急絆創膏であって、使用に際してブリスター
部を指で押圧して薬剤被覆膜を破壊することにより薬剤
をパッドに含浸させるものも知られている（実公昭５４
−２３１９７号公報、米国特許第３，２９７，０３２号
明細書）。There are also known emergency bandages that have a blister part with a drug sealed in it by a drug-coated film, and when used, the pad is impregnated with the drug by pressing the blister part with your finger to break the drug-covering film. (Jikko 54)
-23197, U.S. Pat. No. 3,297,032).
しかしながら、この型の救急絆創膏は、ブリスター部が
平滑な表面を有するものであるため、これを押圧した時
、力がブリスター部全体に分散し、押圧郡全体が不規則
に窪んでしまうため、ブリスター部が薬剤被覆膜に到達
してこれを破壊することは非常に困難であった。However, since the blister part of this type of emergency bandage has a smooth surface, when the blister part is pressed, the force is dispersed over the entire blister part, and the entire pressed area becomes irregularly depressed. It was very difficult for the drug to reach and destroy the drug-coated membrane.
また、例えブリスター部の内部圧力の上昇によって薬剤
被覆膜が破壊された場合でも、破壊箇所はブリスター部
と薬剤被覆膜の接線部分となり、薬剤がパッド外縁部又
はパッド外に移動し、その効果が損なわれるという問題
があった。In addition, even if the drug coating film is destroyed due to an increase in the internal pressure of the blister part, the breakage point will be a tangent between the blister part and the drug coating film, and the drug will move to the outer edge of the pad or outside the pad, and There was a problem that the effect was lost.
また、米国特許第４，１１７，８４１号明細書には接着
剤が塗布された絆創膏ストリップの中央部下表面に、薬
剤を保持する空間を形成して液体不浸透性のシート（或
いは液体不浸透性層を介して液体浸透性のシート）を設
け、該空間内の絆創膏ストリップの下表面にプラスチッ
クの歯のような突起体を設け、また該空間内に薬剤を充
填した絆創膏について記載されている。Further, US Pat. No. 4,117,841 discloses that a space for holding a drug is formed on the central lower surface of an adhesive-coated bandage strip, and a liquid-impermeable sheet (or A bandage is described in which a liquid-permeable sheet is provided between the layers, a plastic tooth-like protrusion is provided on the lower surface of the bandage strip in the space, and a drug is filled in the space.
この絆創膏は、使用に際し、前記シートを突起体に指に
より押しつけ、シートを破壊して薬剤を傷口に直接垂ら
した後、絆創膏を傷口に適用するものであるが、指によ
りシートを突起体に押しつけシートを破壊する操作は、
突起体の先鋭部分により指を痛め、または傷つける恐れ
があり、またシートの破壊時に一部の薬液が指に付着し
、更にその後薬液を傷口に垂らす際に一部の薬液が傷口
から滴り落ちて薬液が無駄になる。また、この絆創膏の
基本的欠点として、絆創膏は突起体が残存したまま、か
つ、その先鋭部分が傷口に向った状態で傷口に適用され
るので、突起体により傷をいっそう傷める危険性があり
、そうでなくても使用感が極めて悪いという欠点を有す
るものである。When using this bandage, the sheet is pressed against the protrusion with a finger, the sheet is broken and the medicine is dripped directly onto the wound, and then the bandage is applied to the wound. The operation that destroys the sheet is
The sharp parts of the protrusions may injure or injure your fingers, and when the sheet is broken, some of the medicinal liquid may adhere to your fingers, and furthermore, when you apply the medicinal liquid to the wound afterwards, some of the medicinal liquid may drip from the wound. Medicinal fluid is wasted. In addition, the basic drawback of this bandage is that the bandage is applied to the wound with the protrusions remaining and the sharp end facing the wound, so there is a risk that the protrusions will further damage the wound. Even if this is not the case, it still has the drawback of being extremely uncomfortable to use.
本発明は上記した従来技術の欠点を解決したものである
。The present invention solves the above-mentioned drawbacks of the prior art.
即ち２本発明の救急絆創膏は、パッドを装着した粘着シ
ートと剥離シートとからなり、剥離シートには、薬剤被
覆膜によりその下面がシールされ、かつ薬剤を内包する
ブリスター部がパッド上に位置して設けられており、前
記薬剤被覆膜にはノー７チが設けられていることを特徴
とする。In other words, the emergency bandage of the present invention consists of an adhesive sheet with a pad attached thereto and a release sheet, the release sheet has its lower surface sealed with a drug coating film, and the blister portion containing the drug is positioned on the pad. The drug coating film is characterized in that the drug coating film is provided with a groove.
本発明の救急絆創膏は、使用に際してブリスター部を指
で押圧して薬剤被覆膜を破壊し、薬剤をパッドに移動さ
せるものであるが、薬剤被覆膜にはノツチが設けられて
いるので、薬剤被覆膜は、そのノツチ部分に於て容易に
破壊され、薬剤はパッドに無駄なく確実に移動する。When the emergency bandage of the present invention is used, the blister part is pressed with a finger to break the drug coating film and transfer the drug to the pad, but since the drug coating film is provided with a notch, The drug coating membrane is easily destroyed at the notch portion, and the drug is reliably transferred to the pad without waste.
このようにして、薬剤をパッドに含浸させた後、薬剤被
覆膜およびブリスター部を有する剥離シートは粘着シー
トから除去される。そして、傷口には薬剤の付いたパッ
ドを有する粘着シートのみが適用されるので使用上の危
険性や違和感がない。After the pad is impregnated with the drug in this manner, the release sheet having the drug coating film and the blister portion is removed from the adhesive sheet. Further, since only the adhesive sheet having the pad with the drug applied thereto is applied to the wound, there is no danger or discomfort during use.
本発明に使用する薬剤については、殺菌消毒剤としてグ
ルコン酸クロルヘキシジン、塩化ベンザルコニウム、ク
ロルキシレノール、アクリノール、チアントール、塩化
デカリニウム、スルフイソミジン、スルファミン、ニト
ロフラゾン、ホウ酸、ホモスルファミン、トリクロカル
パン等があり、創傷部収斂治癒促進剤として酸化亜鉛、
塩酸ピリドキシン、酢酩トコフェロール、シバルミチン
醜ピリドキシン等、止血剤としては塩酸す７７プリン、
硫酸亜鉛、塩酸エフェドリン等、抗炎症剤としてはプレ
ドニゾロン、デキサメサゾン、酢酸コルチゾン等のステ
ロイド剤、グリチルレチン、塩化リゾチーム等、抗ヒス
タミン剤としてマレイン酸クロルフェニラミン、塩酸ジ
フェンヒドラミン等がある。The agents used in the present invention include chlorhexidine gluconate, benzalkonium chloride, chlorxylenol, acrinol, thianthol, dequalinium chloride, sulfisomidine, sulfamine, nitrofurazone, boric acid, homosulfamine, triclocarpan, etc. as disinfectants. , zinc oxide as a wound astringent healing promoter,
Hemostatic agents include pyridoxine hydrochloride, tocopherol in vinegar, sivalmitin pyridoxine, and 77 purine hydrochloride as hemostatic agents.
Anti-inflammatory agents such as zinc sulfate and ephedrine hydrochloride; steroids such as prednisolone, dexamethasone, and cortisone acetate; glycyrrhetin and lysozyme chloride; and antihistamine agents such as chlorpheniramine maleate and diphenhydramine hydrochloride.
又、局麻剤としてはリドカイン、アミノ安息香酸エチル
、塩酸プロ力イン、塩酸ジプカイン、塩酸テトラカイン
、塩酸バラブチルアミノ安息香酸ジエチルアミノエチル
等がある。In addition, topical narcotics include lidocaine, ethyl aminobenzoate, propylene hydrochloride, dypcaine hydrochloride, tetracaine hydrochloride, diethylaminoethyl valbutylaminobenzoate hydrochloride, and the like.
これらの薬剤は目的に合わせ、単味で又は複数の配合剤
とすることができ、又、薬剤の性状は溶液状の他、軟膏
状、グリース状、粉末等流動性のあるものであれば以下
なる性状でもよい。Depending on the purpose, these drugs can be used singly or in combination, and the properties of the drugs are as follows, as long as they are fluid, such as solution, ointment, grease, and powder. It may have the following properties.
粘着シートは、通常用いられるものでもよく、パッドは
、脱脂綿その他各種の綿、不織布等を使用することがで
き、適宜その中央部をへこませた形状とすることができ
る。又１通常の方法により裏面を防水処理してもよい。The pressure-sensitive adhesive sheet may be a commonly used adhesive sheet, and the pad may be made of absorbent cotton, various types of cotton, nonwoven fabric, or the like, and may be appropriately shaped with a concave central portion. Also, the back surface may be waterproofed by a normal method.
剥離シートは、塩化ビニール樹脂その他の合成樹脂等の
材質により成型され、中央部に円形、だ円形若しくは矩
形状のブリスター部を設け、又剥離シートをめくり易く
するために端部にスリットを設けるのがよい。The release sheet is molded from a material such as vinyl chloride resin or other synthetic resin, and has a circular, oval, or rectangular blister section in the center, and slits at the ends to make it easier to turn over the release sheet. Good.
剥離シートのブリスター部下面には、薬剤を使用時まで
パッドに接触させるのを防止するための薬剤被覆膜がシ
ールしである。薬剤被覆膜はアルミ箔、グラシン紙等の
破壊されやすい膜が採用される。該被覆膜は、薬剤を保
護しうる大きさでよいが、剥離シートの下面全体に設け
られていてもさしつかえない。A drug coating film is sealed on the lower surface of the blister of the release sheet to prevent the drug from coming into contact with the pad until use. As the drug coating membrane, a membrane that is easily destroyed, such as aluminum foil or glassine paper, is used. The coating film may be large enough to protect the drug, but may be provided on the entire lower surface of the release sheet.
以下、図面により本発明を更に詳細に説明する。第１図
は、本発明の救急絆創膏の一実施例の断面図、第２図は
第１図のＡ−Ａ ’縦断面図、第３図は剥離シートの平
面図である。Hereinafter, the present invention will be explained in more detail with reference to the drawings. FIG. 1 is a cross-sectional view of one embodiment of the emergency bandage of the present invention, FIG. 2 is a longitudinal cross-sectional view taken along line A-A' in FIG. 1, and FIG. 3 is a plan view of a release sheet.
図面において、ｌはパッド２を装着した粘着シートであ
り、パッド上部には薬剤３が、薬剤被覆膜５と剥離シー
ト４に設けられたブリスター部６との空間内に内包され
ている６１！Ａ薬剤被覆膜５にはノツチが設けられてお
り、また剥離シート４の端部にはスリット７が刻設しで
ある。In the drawing, l is an adhesive sheet to which a pad 2 is attached, and a drug 3 is contained in the space between the drug coating film 5 and the blister portion 6 provided on the release sheet 4 in the upper part of the pad 61! A notch is provided in the drug coating film 5, and a slit 7 is cut in the end of the release sheet 4.
救急絆創膏を使用するに際しては、ブリスター部６を指
で押圧して、薬剤被覆膜５のノツチ部８を破壊すること
により薬剤３をパッドｚ上に移動させる。When using the emergency bandage, the blister portion 6 is pressed with a finger to break the notch portion 8 of the drug coating film 5, thereby moving the drug 3 onto the pad z.
次いで、スリット７を折り曲げ剥離シート４を粘着シー
トｌよりはがし、新鮮な薬剤、の付いたパッド２の部分
を創傷面に当接使用する。Next, the slit 7 is folded, the release sheet 4 is peeled off from the adhesive sheet 1, and the part of the pad 2 with the fresh drug applied is brought into contact with the wound surface.
また、本発明の救急絆創膏に於ては、第４図に示すよう
に、ブリスター部６に凹状の突起９を設けることができ
る。このようにブリスター部に凹状の突起を設けておく
と、該凹状の突起の窪み部分に指をかけて押圧すること
ができるので、ブリスター部の押圧操作がしやすく、そ
して突起部分は形状的にその周辺部分より硬いため、こ
れを上方より押圧すれば突起部分は、その形状が壊れる
ことなく薬剤被覆膜に到達し、その所望の場所、一般的
にはパッドの中央部に対応する箇所の薬剤被覆膜を破壊
するので薬剤のパッドへの移動をより確実に行うことが
４できる。Furthermore, in the emergency bandage of the present invention, a concave projection 9 can be provided on the blister portion 6, as shown in FIG. By providing a concave protrusion in the blister part in this way, it is possible to press the concave part of the concave protrusion with your finger, making it easier to press the blister part. Since it is harder than the surrounding area, if it is pressed from above, the protruding area will reach the drug coating film without breaking its shape, and will reach the desired location, which generally corresponds to the center of the pad. Since the drug coating film is destroyed, the drug can be transferred to the pad more reliably.
本発明の効果は次のとおりである。The effects of the present invention are as follows.
本発明の救急絆創膏は、使用に際してブリスター部を指
で押圧して薬剤被覆膜を破壊し、薬剤をパッドに移動さ
せるものであるが、薬剤被覆膜にはノツチが設けられて
いるので、薬剤被覆膜は、そのノツチ部分に於て容易に
かつ確実に破壊される。そして、薬剤はパッドに無駄な
く確実に移動する。When the emergency bandage of the present invention is used, the blister part is pressed with a finger to break the drug coating film and transfer the drug to the pad, but since the drug coating film is provided with a notch, The drug-coated membrane is easily and reliably destroyed at the notch portion. The medicine is then transferred to the pad reliably without any waste.
また薬剤をパッドに移動させた後、薬剤被覆膜およびブ
リスター部を有する剥離シートは粘着シートから除去さ
れ、傷口には新鮮な薬剤が付いたパッドを有する粘着シ
ートのみが適用され、米国特許第４１１，８４１号明細
古の絆創膏のように突起体のような不安物が傷口部分に
当接されることがないので傷口に対して違和感がなく、
かつ安全に使用することができ、殺菌、消毒、治療の所
望の目的を４１効に達成できるものである。Also, after transferring the drug to the pad, the release sheet with the drug coating film and the blister part is removed from the adhesive sheet, and only the adhesive sheet with the pad with fresh drug is applied to the wound, as disclosed in US Pat. No. 411,841 Specification: Unlike the old bandages, there is no uneasy object such as a protrusion coming into contact with the wound, so there is no discomfort around the wound.
It is safe to use and can effectively achieve the desired purposes of sterilization, disinfection, and treatment.
【図面の簡単な説明】
第１図は本発明の救急絆創膏の平面図、第２図は第１図
のＡ−Ａ ’縦断面図、第３図は第１図の救急絆創膏、
の剥離シートの平面図、第４図は他の実施例における剥
離シートの縦断面図。
ｌ ・・・ 粘着シート
２ ・・・ パッド
３ ・・・ 薬剤
４ ・・・ 剥離シート
５ ・・・ 薬剤被覆膜
６ ・・・ ブリスター部
７ ・・・ スリット
８ ・・・ ノツチ
９ ・・・ 凹状突起
特許出願人 日本臓器製薬株式会社
（ほか２名）
第１図
１・・粘看シート ２・・１１°９ド
３ 奄を１４−４１＃ｋ＞−） ５−
１１？ＩａＩａ ６−ｙｎ？−１７・・又り一
、ト ８・ノ〜−ｆ
９・・凹状突起１牙２図
才３図[BRIEF DESCRIPTION OF THE DRAWINGS] FIG. 1 is a plan view of the emergency bandage of the present invention, FIG. 2 is a longitudinal cross-sectional view taken along line A-A' in FIG. 1, and FIG. 3 is a plan view of the emergency bandage of the present invention.
FIG. 4 is a plan view of a release sheet in another embodiment, and FIG. 4 is a longitudinal cross-sectional view of a release sheet in another embodiment. l... Adhesive sheet 2... Pad 3... Drug 4... Release sheet 5... Drug coating film 6... Blister portion 7... Slit 8... Notch 9... Concave protrusion patent applicant Nippon Kansei Pharmaceutical Co., Ltd. (and 2 others) Figure 1 1.. Adhesive sheet 2.. 11 degrees
3 Amao 14-41#k>-) 5-
11? IaIa 6-yn? -17...Mariichi, G 8.No~-f
9. Concave projection 1 fang 2 figures 3 figures
Claims (1)
、該剥離シートには、薬剤被覆膜によりその下面がシー
ルされ、かつ薬剤を内包するブリスター部が前記パッド
上に位置して設けられており、前記薬剤被覆膜にはノッ
チが設けられていることを特徴とする救急絆創膏。It consists of an adhesive sheet on which a pad is attached and a release sheet, the release sheet has a lower surface sealed with a drug coating film, and a blister portion containing the drug is provided on the pad, An emergency bandage characterized in that the drug coating film is provided with a notch.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP25558987A JPS63119763A (en) | 1987-10-09 | 1987-10-09 | Emergency adhesive plaster |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP25558987A JPS63119763A (en) | 1987-10-09 | 1987-10-09 | Emergency adhesive plaster |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP41091090A Division JPH04329951A (en) | 1990-12-15 | 1990-12-15 | Bandage for emergency |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS63119763A true JPS63119763A (en) | 1988-05-24 |
| JPH0371900B2 JPH0371900B2 (en) | 1991-11-14 |
Family
ID=17280824
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP25558987A Granted JPS63119763A (en) | 1987-10-09 | 1987-10-09 | Emergency adhesive plaster |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS63119763A (en) |
-
1987
- 1987-10-09 JP JP25558987A patent/JPS63119763A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0371900B2 (en) | 1991-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR880003941Y1 (en) | First aid adhesive tape | |
| US2579403A (en) | Medical bandage | |
| US6120792A (en) | Medicated skin patch and method for its use | |
| JP2513712B2 (en) | Wound dressing | |
| US20090099496A1 (en) | Pressure bandage with medication delivery system | |
| US20030004449A1 (en) | Adhesive bandage | |
| JPH0556976B2 (en) | ||
| US3366112A (en) | Adhesive bandage having container of liquid medicament | |
| JP2005509492A (en) | Pharmaceutical material for wound | |
| EP0297828A1 (en) | Novel medicated dressings | |
| US3297032A (en) | Adhesive bandage having container of medicament carried by removable protector strip | |
| EP0254493A1 (en) | Wound dressing, manufacture and use | |
| JPH0157580B2 (en) | ||
| JPS63119763A (en) | Emergency adhesive plaster | |
| WO2007048171A1 (en) | A medicated dressing for wound healing | |
| JPH0136519Y2 (en) | ||
| JPH061135Y2 (en) | First aid bandage | |
| JPS63119764A (en) | Emergency adhesive plaster | |
| JP4136182B2 (en) | Emergency bandage | |
| JPH07308339A (en) | Aseptic packing for wound | |
| JPH03247335A (en) | Emergency adhesive bandage | |
| JPH04329951A (en) | Bandage for emergency | |
| JPH0534649Y2 (en) | ||
| JPH0432099Y2 (en) | ||
| KR880003940Y1 (en) | First aid adhesive tape |